Das Risiko einer diabetischen Mikroangiopathie kann durch genetische Varianten im IL1RN-Gen, welches ein Interleukin 1 kodiert, vermittelt werden.
1. |
Blakemore AI et. al. (1996) Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. |
2. |
Lee SH et. al. () Polymorphisms in interleukin-1 beta and Interleukin-1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. |